Cardiovascular Issues in Male and Female Sexual Dysfunction

Standard Practice in Sexual Medicine

Volumn , Issue , 2008, Pages 376-386

  Jackson, Graham ^a   Hutter, Adolph ^b,c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiovascular issues; Cardiovascular response; Electrocardiogram; Sexual dysfunction; Sexual intercourse

Indexed keywords

EID: 70449371766     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755235.ch28     Document Type: Chapter

References (47)

1. Drory Y. Sexual activity and cardiovascular risk. Eur Heart J 2002;4(suppl H):H13-18.
2. Jackson G, Betteridge J, Dean J, et al. A systematic approach to erectile dysfunction in the cardiovascular patient:a consensus statement: update 2002. Int J Clin Pract 2002;56:633-671.
3. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313-321.
4. Drory Y, Fisman EZ, Shapira Y, et al. Ventricular arrhythmias during sexual activity in patients with coronary artery disease. Chest 1996;109:922-924.
5. Drory Y, Shapira I, Fisman EZ, et al. Myocardial ischaemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995;75:835-837.
6. Müller JE, Mittleman A, MacLure M, et al. Determinants of myocardial infarction onset study investigators. Triggering myocardial infarction by sexual activity:low absolute risk and prevention by regular physical exercise. JAMA 1996;275:1405-1409.
7. Müller J, Ahlbom A, Hulting J, et al. Sexual activity as a trigger of myocardial infarction: a case cross-over analysis in the Stockholm Heart Epidemiology Programme (SHEEP). Heart 2001;86:387-390.
8. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2004;89:251-254.
9. Jackson G. Erectile dysfunction and hypertension. Int J Clin Pract 2002;56:491-492.
10. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychological correlates:results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
11. Kaiser DR, Billups K, Mason C, et al. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004;43(2):179-184.
12. Snow KJ. Erectile dysfunction in patients with diabetes mellitus: advances in treatment with phosphodiesterase Type 5 inhibitors. Br J Diabetes Vasc Dis 2002;2:282-287.
13. Bortolotti A, Parazzini F, Colli E, et al. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997;20:323-334.
14. Kirby M, Jackson G, Betteridge J, et al. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001;55:614-618.
15. Pritzker M. The penile stress test: a window to the heart of the man? [abstract] Circulation 1999;100:3751.
16. Solomon H, Man JW, Wierzbicki AS, et al. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003;91:230-231.
17. Greenstein A, Chen J, Miller H, et al. Does severity of ischaemic coronary disease correlate with erectile function? Int J Impot Res 1997;9:123-126.
18. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the 'Tip of the Iceberg' of a systemic vascular disorder? Eur Urol 2003;44:352-354.
19. Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease? Int J Clin Pract 2005;59:225-229.
20. Montorsi F, Briganti I, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360-365.
21. Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005;2:40-52.
22. Solomon H, Man J, Wierzbicki AS, et al. Erectile dysfunction:cardiovascular risk and the role of the cardiologist. Int J Clin Pract 2003;57:96-99.
23. Brock GB, McMahon CG, Chen KK, et al. Efficiency and safety of tadalafil for the treatment of erectile dysfunction:results of integrated analysis. J Urol 2002;168:1332-1336.
24. Porst H, Rosen R, Padma-Nathan H, et al. Efficacy and tolerability of vardenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction:the first at home clinical trial. Int J Impot Res 2001;13:192-199.
25. Gillies HC, Roblin D, Jackson G. Coronary and systemic haemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. Int J Cardiol 2002;86:131-141.
26. Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2004;42:1855-1860.
27. Jackson G, Martin E, McGing E, Cooper A. Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction. J Sex Med 2005;2:513-516.
28. Padma-Nathan H, ed. Sildenafil citrate (Viagra) and erectile dysfunction: a comprehensive four year update on efficacy, safety, and management approaches. Urology 2002;60(2B):1-90.
29. Mittleman MA, MacClure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. Am J Cardiol 2005;96:443-446.
30. Jackson G, Gillies H, Osterloh I. Past, present and future:a 7-year update of Viagra (sildenafil citrate). Int J Clin Pract 2005;59:680-691.
31. Fox KM, Thadani U, Ma PTS, et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J 2003;24:2206-2212.
32. Herrman HC, Chang G, Klugherz BD, et al. Haemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000;342:1662-1666.
33. Halcox JPJ, Nour KRA, Zalos G, et al. The effect of sildenafil on human vascular function, platelet activation and myocardial ischaemia. J Am Coll Cardiol 2002;40:1232-1240.
34. Katz SD. Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure. Congest Heart Fail 2003;9:9-15.
35. Jackson G, Kloner RA, Costigan TM, et al. Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med 2004;1:161-167.
36. Kloner RA, Jackson G, Emmick JT, et al. Interaction between phosphodiesterase 5 inhibitor, tadalafil, and two alpha blockers, doxazosin and tamsulosin, in healthy normotensive men. J Urol 2004;172:1935-1940.
37. Thadani U, Smith W, Nash S, et al. The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. J Am Coll Cardiol 2002;40:2006-2012.
38. Wagner G, Montorsi F, Auerbach S, Collins M. Sildenafil citrate (Viagra) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis. J Geront 2001;50A:M113-119.
39. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomised study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004;172:658-663.
40. Muller M, Van Der Schouw YT, Thijssen JHH, Grobbee DE. Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab 2003;88:5076-5086.
41. Bruckert E, Giral P, Heshmati HM, Turpin G. Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. J Clin Pharm Ther 1996;21:89-94.
42. Jackson G. Simvastatin and impotence. Brit Med J 1997;351:31.
43. Wenger NK, Collins P, eds. Women and Heart Disease. London: Taylor & Francis, 2005.
44. Riley AJ, Steiner JA, Cooper R, McPherson CK. The prevalence of sexual dysfunction in male and female hypertensive patients. J Sex Marital Ther 1987;2:131-138.
45. Burchardt M, Burchardt T, Anastasiadis AG, et al. Sexual dysfunction is common and overlooked in female patients with hypertension. Sex Marital Ther 2002;28:17-26.
46. Duncan LE, Lewis C, Smith CE, et al. Sex, drugs and hypertension:a methodological approach for studying a sensitive subject. Int J Impot Res 2001;13:31-40.
47. Salonia A, Briganti A, Montorsi P. Sexual dysfunction in women with coronary artery disease. Int J Impot Res 2002;14(suppl 4):S80.